货币 / ARQT
ARQT: Arcutis Biotherapeutics Inc
15.40
USD
0.54
(3.39%)
今日ARQT汇率已更改-3.39%。当日,交易品种以低点15.23和高点15.96进行交易。
关注Arcutis Biotherapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ARQT新闻
- Investing Arcutis Bio EVP Burnett sells $432k in ARQT stock after option exercise
- Investor's Business Daily Western Digital In 9-Week Win Streak, On 2 Top Stock Watchlists: Check Out IBD 50, Stock Spotlight, Others
- Investor's Business Daily Arcutis Biotherapeutics Stock Scores RS Rating Upgrade
- Investing Morgan Stanley assumes coverage of Arcutis Biotherapeutics stock with Overweight rating
- Seeking Alpha Arcutis Biotherapeutics: A Closer Look At The Atopic Dermatitis Direction (NASDAQ:ARQT)
- Investing Arcutis’ ZORYVE ® (roflumilast) Cream 0.15% Receives Strong Recommendation in American Academy of Dermatology Updated Guidelines for Adult Atopic Dermatitis
- Seeking Alpha AMG GW&K Small Cap Core Fund Q1 2025 Commentary
- Seeking Alpha Arcutis Biotherapeutics Stock: Another Approval Under Their Belt (NASDAQ:ARQT)
- Seeking Alpha Arcutis Stock: Out Of The Woods, Ready For Commercialization. (NASDAQ:ARQT)
- Seeking Alpha PGIM Jennison Health Sciences Fund Q1 2025 Commentary (PHLAX)
- Investing Arcutis Enrolls First Child in INTEGUMENT-INFANT Evaluating ZORYVE ® (roflumilast) Cream 0.05% in Infants with Atopic Dermatitis
- Investing H.C. Wainwright maintains $19 target on Arcutis stock
- Investing Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Benzinga Arcutis Unveils Long-Term Efficacy, Safety For Zoryve Cream In Pediatric Patients With Atopic Dermatitis - Arcutis Biotherapeutics (NASDAQ:ARQT)
- Investing Arcutis to Present New Long-Term Results of ZORYVE ® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
- Seeking Alpha Arcutis Stock: Navigating Commercialization With Promising Upside (NASDAQ:ARQT)
- Investing H.C. Wainwright reiterates buy rating and $19 target on Arcutis stock
- Investing Arcutis Biotherapeutics SVP sells $24,806 in stock
- Investing Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
- Investing FDA approves ZORYVE foam for plaque psoriasis treatment
- Investing New Consensus Statements on Impact of Genital Psoriasis on Patients from Genital Psoriasis Wellness Consortium Published in Journal of the European Academy of Dermatology and Venereology Clinical Prac
- Investor's Business Daily Palomar Hits Record High, Joins Sector Leaders. Check Out New Names On IBD 50, Stock Spotlight List And More.
- Investor's Business Daily Entertainment Giant Fox Earns Spot In Big Cap 20: Which Other Stocks Just Came On – And Off – IBD's Top Stock Screens?
- Seeking Alpha Arcutis Stock Opportunity To Capitalize On Leadership, Pipeline, And Commercial Assets
日范围
15.23
15.96
年范围
7.86
17.74
- 前一天收盘价
- 15.90
- 开盘价
- 15.94
- 卖价
- 15.40
- 买价
- 15.70
- 最低价
- 15.23
- 最高价
- 15.96
- 交易量
- 3.271 K
- 日变化
- -3.39%
- 月变化
- 10.87%
- 6个月变化
- 19.47%
- 年变化
- 52.02%
16 七月, 星期三
12:30
USD
- 实际值
- 预测值
- 0.2%
- 前值
- 0.1%
12:30
USD
- 实际值
- 预测值
- 0.1%
- 前值
- 0.1%
12:30
USD
- 实际值
- 预测值
- 2.3%
- 前值
- 2.6%
12:30
USD
- 实际值
- 预测值
- 3.1%
- 前值
- 3.0%
13:15
USD
- 实际值
- 预测值
- 0.1%
- 前值
- -0.2%
13:15
USD
- 实际值
- 预测值
- 77.1%
- 前值
- 77.4%
13:15
USD
- 实际值
- 预测值
- -0.2%
- 前值
- 0.1%
13:15
USD
- 实际值
- 预测值
- 0.6%
- 前值
- 0.6%
14:00
USD
- 实际值
- 预测值
- 前值
14:30
USD
- 实际值
- 预测值
- 0.681 M
- 前值
- 7.070 M
14:30
USD
- 实际值
- 预测值
- -0.032 M
- 前值
- 0.464 M
14:30
USD
- 实际值
- 预测值
- 0.093 M
- 前值
- -1.358 M
14:30
USD
- 实际值
- 预测值
- -0.023 M
- 前值
- 0.059 M
14:30
USD
- 实际值
- 预测值
- -0.801 M
- 前值
- -0.825 M
14:30
USD
- 实际值
- 预测值
- -0.640 M
- 前值
- 0.278 M
14:30
USD
- 实际值
- 预测值
- 0.169 M
- 前值
- 0.603 M
14:30
USD
- 实际值
- 预测值
- 1.803 M
- 前值
- -2.658 M
14:30
USD
- 实际值
- 预测值
- 前值
- -0.099 M
14:30
USD
- 实际值
- 预测值
- 前值
- -0.2%
18:00
USD
- 实际值
- 预测值
- 前值
22:30
USD
- 实际值
- 预测值
- 前值